Cargando…
Triamcinolone acetonide combined with aminoguanidine inhibits inflammation and oxidative stress, improves vascular endothelial and retinal function and reduces VEGF expression in diabetic retinopathy patients
Effects of triamcinolone acetonide (TA) combined with aminoguanidine (AG) on vascular endothelial function, vascular endothelial growth factor (VEGF) expression and retinal function in diabetic retinopathy (DR) patients were studied. A total of 100 patients with DR admitted to the Taizhou Second Peo...
Autores principales: | Xu, Kai, Qian, Hanliang, Zou, Meibo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086164/ https://www.ncbi.nlm.nih.gov/pubmed/32256730 http://dx.doi.org/10.3892/etm.2020.8478 |
Ejemplares similares
-
Effects of Switching from Anti-VEGF Treatment to Triamcinolone Acetonide in Eyes with Refractory Macular Edema Associated with Diabetic Retinopathy or Retinal Vein Occlusion
por: Tatsumi, Tomoaki, et al.
Publicado: (2020) -
Triamcinolone acetonide acetate
por: Lu, Xiao, et al.
Publicado: (2011) -
Adjunct Intravitreous Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema with Anti-VEGF Agents
por: Garoon, Robert B., et al.
Publicado: (2016) -
Pharmacokinetics and retinal toxicity of various doses of intravitreal triamcinolone acetonide in rabbits
por: Ye, You-Fan, et al.
Publicado: (2014) -
Trabeculectomy with intraoperative retrobulbar triamcinolone acetonide
por: Kahook, Malik Y, et al.
Publicado: (2009)